Tag: CEO
Pfizer aims to ship COVID vaccine doses ‘within hours’ of regulatory...
After Pfizer’s leading COVID-19 vaccine turned in strong data in a late-stage trial, the company planned to submit its program to U.S. authorities for an emergency use authorization “within...
Pfizer CEO: We may cut jobs, backpedal on expansions if Trump’s...
President Donald J. Trump's recent spate of executive orders targeting U.S. drug prices has received heaps of scorn from the pharmaceutical industry and its...
Biogen’s lagging Vumerity, stalled by the pandemic, faces ‘critical’ stretch ahead,...
Biogen’s Tecfidera follow-up Vumerity hit the market late last year, but eight months into the launch, the new multiple sclerosis drug is yet to meaningfully take off.
The drug...
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO...
As Amgen ramps up a clinical trial of its psoriasis drug Otezla in COVID-19, the company’s scientists may be seriously considering whether another of...
Former Indivior CEO pleads guilty in federal Suboxone probe a day...
Federal prosecutors have hounded opioid maker Indivior for years over its marketing of Suboxone Film as a safe painkiller despite addiction risks. After snaring...
Sanofi weighs job cuts as part of CEO Paul Hudson’s ‘roadmap’:...
Under CEO Paul Hudson, Sanofi is seeking to cut costs, among other goals. One route it's considering? Job cuts, Reuters reports.
The drugmaker is weighing hundreds of layoffs, sources...
AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just...
AstraZeneca, advancing a COVID-19 vaccine from the University of Oxford, is among global frontrunners in the worldwide hunt for a viable vaccine. Now, the drugmaker’s CEO...
Are metformin recalls just the start? Valisure CEO calls for independent...
With another quality scandal on its hands with diabetes drug metformin, the FDA could be looking at another global recall of a commonly used med....
Sanofi CEO: Up-front funding wins U.S. first access to coronavirus shot
As questions swirl over equitable access to COVID-19 vaccines, Sanofi CEO Paul Hudson has laid out some of his company’s plans should its program...
Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies
Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials and an antibody cocktail in development....
